Trial of Epinephrine and Albuterol in Bronchiolitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00114478|
Recruitment Status : Unknown
Verified January 2008 by Kern Medical Center.
Recruitment status was: Active, not recruiting
First Posted : June 16, 2005
Last Update Posted : January 25, 2008
The purpose of this study is to see which of the two most common drugs used to treat bronchiolitis works better. A child's participation in this study is expected to last less than 4 hours. Approximately 600 patients will be recruited to participate in this study at Kern Medical Center (KMC).
Bronchiolitis is a very common lung infection in babies. There are many drugs used to treat this disease but nobody knows which one, if any, works the best. Two of the most commonly used drugs are albuterol and epinephrine. These are both drugs given during breathing treatments with oxygen and a mask. We are doing this study to see which of these drugs works better or if they are both equally good. The study works as follows: after the consent process the baby gets three treatments.
- Nebulizer 1 (Treatment)
- Treatment + 30 minutes (approximately) Nebulizer 2
- Treatment + 60 minutes (approximately) Nebulizer 3
- Treatment + 120 minutes (approximately)
The baby will be reevaluated and either discharged home or revert to standard therapy. If the baby is discharged directly from the emergency department (E.D.), we will call you in three days time to see how he/she is doing.
|Condition or disease||Intervention/treatment|
|Bronchiolitis||Drug: Epinephrine Drug: albuterol (salbutamol)|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||600 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Controlled Trial of Epinephrine and Albuterol in Bronchiolitis|
|Study Start Date :||November 2003|
|Estimated Study Completion Date :||May 2006|
- Successful hospital discharge at three days
- Improvement in severity of disease score
- Improvement in respiratory status
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00114478
|United States, California|
|Kern Medical Center|
|Bakersfield, California, United States, 93312|
|Principal Investigator:||Paul Walsh, Paul Walsh, MD MSc(peds)||Kern Medical Center, David Geffen School of Medicine, UCLA|
|Principal Investigator:||Paul Walsh||Research Director, Emergency Medicine|